Latest Schedule 13G passive stakes

Iroquois Capital Management LLC, Richard Abbe, and Kimberly Page have collectively reported beneficial ownership of 5.14% of XWELL, Inc. common stock as of June 1, 2026.

Merus Global Investments, LLC has filed a Schedule 13G reporting a 5.1% beneficial ownership stake in D. Boral ARC Acquisition I Corp.

Harraden Circle Investments and affiliated entities have reported an 8.77% beneficial ownership stake in Aeon Acquisition I Corp.

Tang Capital Management and Kevin Tang have reported an 8.2% beneficial ownership stake in Fulcrum Therapeutics, Inc. via a Schedule 13G filing.

Portolan Capital Management and George McCabe have filed a Schedule 13G reporting a 5.19% beneficial ownership stake in Tecogen Inc.

Alon Abady and affiliated entities have filed a Schedule 13G reporting a 9.99% beneficial ownership stake in Patriot National Bancorp, Inc.

Glazer Capital, LLC and Paul J. Glazer have filed a Schedule 13G disclosing that their beneficial ownership in KalVista Pharmaceuticals has fallen below the 5% threshold.

Millennium Management LLC and affiliated entities have reported a significant beneficial ownership stake of 7.2% in Quince Therapeutics, Inc.

Joel Arberman has filed a Schedule 13G, disclosing beneficial ownership of 350,000 warrants representing 4.99% of Onfolio Holdings, Inc.'s common stock.

Jeffrey David Weiner has filed a Schedule 13G, reporting beneficial ownership of 59,750 shares, representing 2.61% of Psyence Biomedical Ltd.'s common stock.

Andrew Berger and associated entities, AB Value Management LLC and AB Value Partners, LP, have disclosed a beneficial ownership of 7.1% in FONAR Corporation's common stock.

Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife have filed a Schedule 13G, reporting no beneficial ownership of ReTo Eco-Solutions, Inc. Class A Shares as of June 10, 2026.

James C. Jones has reported beneficial ownership of 92,812 shares, representing 14.99% of the common stock of Global Innovative Platforms Inc., as of March 31, 2021.

MEITAV Investment House Ltd. and its subsidiary MEITAV PROVIDENT FUNDS & PENSION LTD. have filed a Schedule 13G, reporting a combined beneficial ownership of approximately 28.99% of G Willi Food International Ltd.'s ordinary shares.

Meitav Investment House Ltd. and its subsidiaries have reported a significant beneficial ownership stake in TAT Technologies Ltd., totaling approximately 18.48% of the company's ordinary shares.

Kelly Habbas has filed a Schedule 13G, reporting beneficial ownership of 369,000 Class A Ordinary Shares, representing 21.5% of the class, in WORK Medical Technology Group LTD.

ReposiTrak, Inc. has filed a Schedule 13G reporting beneficial ownership of 14.8% of SPAR Group, Inc. common stock.

ReposiTrak, Inc. has filed a Schedule 13G reporting beneficial ownership of 14.8% of SPAR Group, Inc. common stock.

Venrock Healthcare Capital Partners and affiliates have reported a 6.2% beneficial ownership stake in Relmada Therapeutics, Inc.

Strategic EP, LLC and Alexander Chase Deitch have filed a Schedule 13G disclosing a 5.1% beneficial ownership stake in Lixte Biotechnology Holdings, Inc.

Jane Street Group, LLC has reported a 5.1% beneficial ownership stake in Bitdeer Technologies Group as of June 3, 2026.

Jane Street Group, LLC has filed a Schedule 13G reporting a 5.6% beneficial ownership stake in GeoVax Labs, Inc.

Global Frontier Investments and W. Grant Dollens report a reduction in their beneficial ownership of Infleqtion, Inc. common stock following in-kind distributions.

RichRich Capital LLC and Rich Huang have filed a Schedule 13G reporting a 0.32% beneficial ownership stake in Virgin Galactic Holdings, Inc. through call options.

Millennium Management LLC and associated entities have filed a Schedule 13G disclosing they no longer hold a greater than 5% beneficial interest in Long Table Growth Corp.

Laurence W. Lytton and the Lytton-Kambara Foundation have filed a Schedule 13G reporting a 9.99% beneficial ownership stake in SINTX Technologies, Inc.

Point72 Asset Management and Steven A. Cohen have reported a 5.1% beneficial ownership stake in Design Therapeutics, Inc.

Stonepine Capital Management, LLC and affiliated entities report beneficial ownership of 9.9% of SINTX Technologies, Inc. common stock.

Phoenix Financial Ltd. has disclosed a beneficial ownership of 4.99% in Sol-Gel Technologies Ltd. as of June 2, 2026.

Phoenix Financial Ltd. has disclosed beneficial ownership of 5.01% of Tower Semiconductor Ltd.'s ordinary shares, representing 5,654,349.46 shares as of June 5, 2026.